18F ML-10 for Early Detection of Response of Brain Metastases to SRS
NCT00696943
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
Replaced by a global study protocol NST-CA004
Conditions
Metastasis to Brain of Unknown Primary
Interventions
DRUG:
([18F]-ML-10)
Sponsor
Aposense Ltd.